AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Reuters

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Reuters

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks Reuters

March 12, 2026 at 09:01 AM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

USA

Tags

drug safety health risks impurity lilly medicine weight loss weight-loss drug

All Coverage

Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxOV0dqMWtESjYyck5UMktyX3E1S3Q4cWVHR2UtZWVKYmpHLW0xREpuWThOOUFtcVcwMGx6ZG9nOG14MXBBQmVTOFl4T0V4XzkzU3ZMSlhJd2VpeWNFU1pGWXJGZTkxelRMcGl5Wko0cjc5TkhrUm5PUnBVNVdwUTRRc0FyY1dqVDZHQXhFZWV1U243UjlUSXBsajVFeVh5XzJpM1lXMGlwNld1RkdaWk9RUHRyQ0hmOWE3dU5yZlVZUDN0Y0VWSU1hREJwYUVpMVdHSHJqWGV0YTRrNkJPbWptNXdscnZLdw?oc=5" target="_blank">Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters

WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters

October 7, 2026 at 07:39 AM

US FDA flags four deaths in Newron's schizophrenia drug studies - Reuters

US FDA flags four deaths in Newron's schizophrenia drug studies Reuters

October 8, 2026 at 05:47 PM

PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters

PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters

October 7, 2026 at 11:36 AM

US FDA expands use of Novartis drug for chronic skin condition - Reuters

US FDA expands use of Novartis drug for chronic skin condition Reuters

October 7, 2026 at 04:51 PM

EXCLUSIVE: US consumer watchdog examiners adopt lighter touch amid pressure and threats, sources say - Reuters

EXCLUSIVE: US consumer watchdog examiners adopt lighter touch amid pressure and threats, sources say Reuters

October 7, 2026 at 10:51 AM

Reliance sues India's food regulator over 'energy drink' label ban - Reuters

Reliance sues India's food regulator over 'energy drink' label ban Reuters

October 6, 2026 at 04:18 AM